Published by ChinaMNC · Ludian

Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Herbs: What Foreign Founders Should Know

A practical overview of Yunnan Province's 2026–2030 plan for the Chinese medicinal herb sector, covering variety priorities, GAP bases, under-forest cultivation, processing, market stabilization, food-medicine products, and AI, for foreign founders operating in China.

Why This Plan Matters for Foreign Founders

Yunnan's provincial government has issued a plan for the Chinese medicinal herb industry through 2030. For foreign founders building businesses in China around botanicals, health products, cosmetics, or agricultural supply chains, the plan signals where provincial support, standards, and infrastructure are heading. It also shows how the province intends to shift from volume to value, which affects sourcing and partnership decisions.

The headline targets: by 2030, the planted area for medicinal herbs is expected to fall by 1.608 million mu, while comprehensive output value is targeted to rise by 50 billion yuan. The province frames this as trading area for gains in quality, processing, branding, and efficiency. Foreign founders should read this as a quality-upgrade story rather than an expansion story.

Variety Priorities: What Gets Focused Support

The plan builds on the 156 varieties listed in the 2024 edition of Yunnan's Dao-di (authentic regional) herb catalogue. It groups priorities into three tiers.

Established strengths

The "Top Ten Yunnan Herbs" lead this tier: Panax notoginseng, Yunnan Paris polyphylla, Erigeron breviscapus, Dendrobium officinale, Amomum villosum, Gastrodia elata, Yunnan Poria, Yunnan Angelica sinensis, Yunnan Aucklandia lappa, and Yunnan Gentiana.

Health-oriented resources

The "Top Ten Health Resources" include Polygonatum kingianum, safflower, Bletilla striata, purple-skinned Dendrobium, Phyllanthus emblica (Yunnan olive), Coix seed, Terminalia chebula, Amomum tsaoko, ginger, and star anise.

Potential varieties

The "Six Southern Medicines" cover Amomum villosum, dragon's blood, Cibotium barometz, agarwood, Orthosiphon aristatus, and Dai Bai Jie. Founders evaluating ingredient pipelines should note which tier their inputs fall into, since tier placement likely correlates with where provincial attention and standard-setting effort concentrate.

Cultivation and Standards: GAP Bases and Under-Forest Growing

The plan targets 200 Good Agricultural Practice (GAP) bases for medicinal herbs. A key focus is full GAP coverage for Wenshan Panax notoginseng, with orderly development of GAP bases for under-forest varieties such as Poria, Amomum villosum, Amomum tsaoko, and Phellodendron. The province also aims to develop a set of national-level high-standard raw material production bases.

On where cultivation happens, the plan focuses on Dao-di herbs including Panax notoginseng, Gastrodia elata, Poria, Amomum villosum, Polygonatum, and Phellodendron. It promotes under-forest cultivation and rearing, with ecological and under-forest bases to expand to more than 6 million mu.

For foreign founders, GAP status matters for supply contracts, traceability claims, and export documentation. Building relationships with GAP-base operators early may be more valuable than sourcing from open markets.

Processing: From Raw Material to Semi-Industrial Inputs

The plan supports establishing origin processing lines in Dao-di production areas and at high-standard raw material bases. It links GAP-base herbs with fresh-cut processing and pushes products from primary raw materials toward semi-industrial input materials. This is directly relevant to foreign founders who need consistent, specification-ready inputs rather than raw agricultural commodities.

The plan also supports enterprises building modern deep-processing lines and developing high-value-added products, forming a series of Yunnan herb health products. It promotes R&D and industrialization of health products in areas such as personal care and cosmetics, and functional wellness.

Market Stability and Risk Management

For bulk and scarce varieties vulnerable to market swings, notably Panax notoginseng, Angelica sinensis, and Paris polyphylla, the plan calls for market-based adjustment to smooth volatility. It also calls for an information monitoring and early-warning system to flag industry risks such as盲目 expansion and prices falling enough to hurt farmers.

Foreign founders sourcing these inputs should anticipate possible price and supply variability, and should build contractual flexibility. The early-warning system may eventually provide useful public signals, though the plan does not specify its data or access arrangements.

Food-Medicine and Cross-Border Products

The plan calls for standards for food-medicine homology raw materials and production processing. It targets completing cross-border registration for 5 to 10 new products and plans a Yunnan Herb Food-Medicine Culture Festival.

Cross-border registration is a concrete opening for founders with product concepts that bridge food and medicine categories. However, the plan does not specify which markets or product categories are involved, so founders should verify details with relevant authorities before committing.

Digital and AI Initiatives

The plan includes a "Yunnan Herb Brain" AI innovation application project, building an intelligent application system covering the full lifecycle of medicinal herbs. It focuses on key areas and aims to form multi-level, multi-scenario intelligent solutions.

For founders in agritech or supply-chain software, this suggests potential collaboration space, though the plan does not detail procurement, partnership, or funding mechanisms.

Practical Takeaways for Foreign Founders

• Map your inputs to the priority tiers. Knowing whether your ingredients are established strengths, health resources, or potential varieties helps you anticipate standards and support.
• Prioritize GAP-based supply. The 200-base target and Wenshan Panax notoginseng coverage indicate where formalized supply is heading.
• Consider under-forest sourcing. The expansion to over 6 million mu signals growing availability of ecologically cultivated materials.
• Plan for processing, not just raw materials. The push toward semi-industrial inputs and deep processing may create partnership opportunities with local processors.
• Watch standards development. Food-medicine homology standards and cross-border registrations are areas where early engagement could matter.
• Build flexibility into contracts. Market stabilization measures for volatile varieties suggest price and supply management will remain active.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.